Published in Proc Natl Acad Sci U S A on September 08, 2003
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov (2010) 5.55
Life history of eNOS: partners and pathways. Cardiovasc Res (2007) 2.53
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol (2009) 2.49
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med (2010) 2.41
Targeting SphK1 as a new strategy against cancer. Curr Drug Targets (2008) 1.91
Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest (2004) 1.67
Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br J Pharmacol (2004) 1.48
The vascular S1P gradient-cellular sources and biological significance. Biochim Biophys Acta (2008) 1.38
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol (2007) 1.31
Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell (2009) 1.31
Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood (2008) 1.30
microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Oncotarget (2014) 1.22
Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res (2009) 1.19
Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. PLoS One (2011) 1.19
Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. Br J Pharmacol (2011) 1.16
Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. J Lipid Res (2008) 1.13
Steroidogenic factor-1 is a sphingolipid binding protein. Mol Cell Endocrinol (2006) 1.12
Targeting sphingosine-1-phosphate for cancer therapy. Br J Cancer (2006) 1.11
Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate. J Lipid Res (2010) 1.06
Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J Virol (2010) 1.06
Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibility. J Allergy Clin Immunol (2010) 1.04
Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices. Am J Physiol Heart Circ Physiol (2008) 1.03
Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci (2006) 0.99
Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp Eye Res (2008) 0.99
Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J Cell Physiol (2009) 0.97
Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials (2010) 0.94
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction. Am J Physiol Heart Circ Physiol (2009) 0.93
S1P metabolism in cancer and other pathological conditions. Biochimie (2010) 0.92
Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. Proc Natl Acad Sci U S A (2004) 0.92
Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol (2007) 0.92
Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma. J Cell Biochem (2008) 0.91
Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries. Pharmacol Res (2010) 0.90
Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. Br J Pharmacol (2011) 0.90
Roles of sphingosine 1-phosphate on tumorigenesis. World J Biol Chem (2011) 0.89
Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1. Cell Death Dis (2013) 0.86
The impact of bioactive lipids on cardiovascular development. Stem Cells Int (2011) 0.85
Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation. J Cell Mol Med (2010) 0.85
Virus interactions with endothelial cell receptors: implications for viral pathogenesis. Curr Opin Virol (2014) 0.84
Sphingolipid modulation of angiogenic factor expression in neuroblastoma. Cancer Prev Res (Phila) (2011) 0.84
Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesis. J Lipid Res (2008) 0.84
Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol (2004) 0.84
Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling. Differentiation (2013) 0.83
Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature. J Am Soc Nephrol (2014) 0.82
Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthma. Immunol Cell Biol (2009) 0.82
Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth. Am J Physiol Cell Physiol (2014) 0.81
Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. Biochem J (2014) 0.80
Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation. PLoS One (2014) 0.80
Harnessing systems biology approaches to engineer functional microvascular networks. Tissue Eng Part B Rev (2010) 0.80
Local effects of the sphingosine 1-phosphate on prostaglandin F2alpha-induced luteolysis in the pregnant rat. Mol Reprod Dev (2009) 0.77
Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist. PLoS One (2014) 0.77
Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P). PLoS One (2015) 0.76
Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy? Invest Ophthalmol Vis Sci (2015) 0.76
Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2. Mediators Inflamm (2016) 0.75
Sphingosine 1-phosphate and cancer: lessons from thyroid cancer cells. Biomolecules (2013) 0.75
Identification of the S100 fused-type protein hornerin as a regulator of tumor vascularity. Nat Commun (2017) 0.75
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell (1999) 5.01
Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem (1996) 3.75
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med (2002) 3.74
Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature (1993) 3.58
Role of plasmalemmal caveolae in signal transduction. Am J Physiol (1998) 2.77
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene (1999) 2.66
An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem (1990) 2.65
Lysophospholipids--receptor revelations. Science (2001) 2.61
The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem (2000) 2.44
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest (1996) 2.36
Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol (1994) 2.31
Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem (1999) 2.22
Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science (2001) 2.17
Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis (1995) 2.02
Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell (2001) 2.02
Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem (2001) 1.94
Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem (1996) 1.93
Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol (1993) 1.92
Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem (1998) 1.89
Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem (1999) 1.74
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem (2001) 1.72
Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem (2002) 1.57
Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem (2001) 1.56
The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J Biol Chem (1996) 1.54
Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem (2001) 1.50
Signaling via vascular endothelial growth factor receptors. Exp Cell Res (1999) 1.49
Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J Biol Chem (1993) 1.49
Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochem Pharmacol (1999) 1.44
Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler Thromb Vasc Biol (2002) 1.42
Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol (2000) 1.42
Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem (2000) 1.35
Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun (1997) 1.33
Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem (2000) 1.27
Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol Cell Biol (2000) 1.27
Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways. J Biol Chem (2001) 1.25
Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem (2000) 1.24
Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol (2003) 1.18
Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol (1995) 1.17
An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression. J Biol Chem (2001) 1.15
Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. Eur J Biochem (2000) 0.96
A novel function of sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cells. J Physiol (2001) 0.86
The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol (2006) 2.68
Life history of eNOS: partners and pathways. Cardiovasc Res (2007) 2.53
Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med (2015) 2.12
Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem (2005) 1.96
Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK -> Rac1 -> Akt -> endothelial nitric-oxide synthase pathway. J Biol Chem (2007) 1.91
PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest (2008) 1.68
The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest (2007) 1.67
Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy. Cell Cycle (2009) 1.63
Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg (2003) 1.55
Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arterioscler Thromb Vasc Biol (2003) 1.50
Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem (2002) 1.44
Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J Biol Chem (2004) 1.43
Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells. J Biol Chem (2005) 1.34
Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites. Biochemistry (2002) 1.27
Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc Natl Acad Sci U S A (2011) 1.25
Epinephrine regulation of the endothelial nitric-oxide synthase: roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling. J Biol Chem (2007) 1.20
Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells. J Biol Chem (2009) 1.20
Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res (2009) 1.19
Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol (2003) 1.18
Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem (2005) 1.16
Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium. J Biol Chem (2007) 1.15
Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta. J Biol Chem (2009) 1.11
Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J Biol Chem (2002) 1.10
Enhanced oxidative stress as a potential mechanism underlying the programming of hypertension in utero. J Cardiovasc Pharmacol (2002) 1.09
Endothelial nitric oxide synthase negatively regulates hydrogen peroxide-stimulated AMP-activated protein kinase in endothelial cells. Proc Natl Acad Sci U S A (2009) 1.04
S-Nitrosation and regulation of inducible nitric oxide synthase. Biochemistry (2005) 1.02
The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells. J Biol Chem (2010) 1.00
Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab (2013) 0.97
Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase. Biochemistry (2002) 0.97
Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. J Clin Invest (2016) 0.93
Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. Am J Physiol Heart Circ Physiol (2009) 0.93
S1P and eNOS regulation. Biochim Biophys Acta (2008) 0.92
Thiol-metabolizing proteins and endothelial redox state: differential modulation of eNOS and biopterin pathways. Am J Physiol Heart Circ Physiol (2009) 0.92
Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol (2009) 0.92
HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas. Neuromolecular Med (2014) 0.89
Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling. Biochemistry (2005) 0.88
What's in a name? eNOS and anaphylactic shock. J Clin Invest (2006) 0.88
Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis. Proc Natl Acad Sci U S A (2004) 0.87
Angiotensin-II and MARCKS: a hydrogen peroxide- and RAC1-dependent signaling pathway in vascular endothelium. J Biol Chem (2012) 0.87
Receptor-regulated dynamic interaction between endothelial nitric oxide synthase and calmodulin revealed by fluorescence resonance energy transfer in living cells. Biochemistry (2003) 0.87
Role of Ca2+ in the control of H2O2-modulated phosphorylation pathways leading to eNOS activation in cardiac myocytes. PLoS One (2012) 0.86
Resveratrol protects against cigarette smoke-induced oxidative damage and pulmonary inflammation. J Biochem Mol Toxicol (2014) 0.86
Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling. Sci Signal (2013) 0.85
MARCKS protein mediates hydrogen peroxide regulation of endothelial permeability. Proc Natl Acad Sci U S A (2012) 0.85
Associations between sleep duration, daytime nap duration, and osteoporosis vary by sex, menopause, and sleep quality. J Clin Endocrinol Metab (2014) 0.85
Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J (2012) 0.84
NO way to relax: the complexities of coupling nitric oxide synthase pathways in the heart. Circulation (2010) 0.84
Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. Arterioscler Thromb Vasc Biol (2013) 0.83
Nitric oxide signaling comes of age: 20 years and thriving. Cardiovasc Res (2007) 0.83
ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase. J Biol Chem (2009) 0.82
Development and trialling of a tool to support a systems approach to improve social determinants of health in rural and remote Australian communities: the healthy community assessment tool. Int J Equity Health (2013) 0.81
siRNA directed against Livin inhibits tumor growth and induces apoptosis in human glioma cells. J Neurooncol (2011) 0.80
Polymorphism of the RAGE affects the serum inflammatory levels and risk of ischemic stroke in a Chinese population. Cell Physiol Biochem (2013) 0.80
Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells. Biochim Biophys Acta (2013) 0.79
Estrogen regulation of tumor necrosis factor-alpha: a missing link between menopause and cardiovascular risk in women? Hypertension (2005) 0.79
A New Strategy for the Synthesis of alpha-Difluoromethyl-Substituted alpha-Hydroxy and alpha-Amino Acids. J Org Chem (1996) 0.79
From olive drupes to olive oil. An HPLC-orbitrap-based qualitative and quantitative exploration of olive key metabolites. Planta Med (2013) 0.78
Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents. Curr Med Chem (2015) 0.78
Central role for hydrogen peroxide in P2Y1 ADP receptor-mediated cellular responses in vascular endothelium. Proc Natl Acad Sci U S A (2014) 0.78
Prenatal diagnostics of cleft deformities and its significance for parent and infant care. J Craniomaxillofac Surg (2006) 0.78
Suppression of Gαs synthesis by simvastatin treatment of vascular endothelial cells. J Biol Chem (2011) 0.78
The enigma of sphingosine 1-phosphate synthesis: a novel role for endothelial sphingosine kinases. Circ Res (2008) 0.77
Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study. Thromb Haemost (2009) 0.77
Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents Curr Med Chem (2015) 0.77
[Effect of Sheshang capsule on platelet function of rabbits bitten by Trimeresurus stejnegeri and its mechanism]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue (2014) 0.77
Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis? Circ Res (2006) 0.77
Insulin signaling in vascular endothelial cells: a key role for heterotrimeric G proteins revealed by siRNA-mediated Gbeta1 knockdown. Biochemistry (2006) 0.76
Magnetic resonance imaging appearance of the medial wall of the cavernous sinus for the assessment of cavernous sinus invasion by pituitary adenomas. J Neuroradiol (2013) 0.76
In vivo imaging of nitric oxide and hydrogen peroxide in cardiac myocytes. Methods Enzymol (2013) 0.76
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study. Thromb Haemost (2008) 0.76
Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med (2015) 0.75
Regulation of ACE2 and ANG-(1-7) in the aorta: new insights into the renin-angiotensin system in the control of vascular function. Am J Physiol Heart Circ Physiol (2005) 0.75
Restoration of renal allograft function via reduced-contrast percutaneous revascularization of transplant renal artery stenosis. Tex Heart Inst J (2015) 0.75
Corrigendum: Increased water salinity applied to tomato plants accelerates the development of the leaf miner Tuta absoluta through bottom-up effects. Sci Rep (2016) 0.75
Protective effect of a Butea monosperma (Lam.) Taub. flowers extract against skin inflammation: antioxidant, anti-inflammatory and matrix metalloproteinases inhibitory activities. J Ethnopharmacol (2013) 0.75